Copyright and gene technology.
The rapid growth of gene technology and its commercialisation raises concerns for scientific researchers and research institutions wishing to place information in the public domain. This article examines whether copyright laws in the United States, United Kingdom and Australia provide any protection for genetically modified DNA, proteins, and genetically modified organisms, in contrast with any copyright protection extending to a record of the lettering of a sequence representing a series of nucleotides of modified DNA or the amino acids comprising a protein. Whilst it is arguable that protection may be available in the United States and the United Kingdom, it is submitted that it would be difficult to persuade a court in Australia that genetically modified DNA and genetically modified organisms directly constitute "literary" or "artistic" works.
Coke
Sue
S
Science and Research Policy and Strategy Group, Department of Innovation and Information Economy, Sport and Recreation, Queensland.
D001315:Australia; D003309:Copyright / Q000331:legislation & jurisprudence*; D004247:DNA / Q000235:genetics; D005818:Genetic Engineering / Q000331:legislation & jurisprudence*; D006801:Humans; D030781:Organisms, Genetically Modified / Q000235:genetics; D015202:Protein Engineering; D009626:Terminology as Topic; D006113:United Kingdom; D014481:United States
D004247:DNA